Insulin resistance and microalbuminuria are associated with microvascular disease in patients with cirrhosis

Karen Krok, Farida Milwalla, Anurag Maheshwari, Rebecca Rankin, Paul J. Thuluvath

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cardiovascular (CV) disease has a significant impact on post-liver transplantation (LT) survival. Finding surrogate markers for occult CV disease would improve CV assessment in the LT evaluation. This study was designed to determine the prevalence of microvascular disease (MVD) and the utility of both microalbuminuria and the homeostatic model for insulin resistance (HOMA-IR) for assessing the presence of MVD in potential LT recipients. In this study, we examined the prevalence of MVD in 72 diabetics and 71 nondiabetics; both groups were matched for age, sex, race, and etiology of cirrhosis while awaiting LT. We prospectively collected data including fasting serum insulin and glucose levels, urine creatinine and microalbumin, and macrovascular and microvascular complications. MVD was present in 58 (40.5%) patients; MVD was more common in diabetics (n = 45, 62.5%) than nondiabetics (n = 13, 18.3%). The presence of diabetes mellitus (DM; P = 0.03), insulin use (P = 0.002), and duration (months) of DM (85.3 ± 96.1 versus 22.1 ± 46.3, P = 0.0001), hypertension (51.3 ± 101.5 versus 22.7 ± 58.2, P = 0.03), and hypertriglyceridemia (7.2 ± 17.4 versus 3.8 ± 18.5, P = 0.04) were associated with MVD. Significant microalbuminuria had a sensitivity of 85%, a specificity of 100%, and a positive predictive value of 100% for the presence of MVD. HOMA-IR also was associated with MVD (P = 0.0001). In conclusion, at our center, 62.5% of DM patients and 18% of non-DM patients awaiting LT have MVD. Patients with DM, significant microalbuminuria, or an elevated HOMA-IR should undergo rigorous CV assessment prior to LT.

Original languageEnglish (US)
Pages (from-to)1036-1042
Number of pages7
JournalLiver Transplantation
Volume15
Issue number9
DOIs
StatePublished - Jan 1 2009

Fingerprint

Insulin Resistance
Fibrosis
Liver Transplantation
Cardiovascular Diseases
Insulin
Hypertriglyceridemia
Fasting
Creatinine
Diabetes Mellitus
Research Design
Biomarkers
Urine
Hypertension
Glucose
Survival
Serum

All Science Journal Classification (ASJC) codes

  • Surgery
  • Hepatology
  • Transplantation

Cite this

Krok, Karen ; Milwalla, Farida ; Maheshwari, Anurag ; Rankin, Rebecca ; Thuluvath, Paul J. / Insulin resistance and microalbuminuria are associated with microvascular disease in patients with cirrhosis. In: Liver Transplantation. 2009 ; Vol. 15, No. 9. pp. 1036-1042.
@article{f166c1af989d4cc0afd1d52fa9a16563,
title = "Insulin resistance and microalbuminuria are associated with microvascular disease in patients with cirrhosis",
abstract = "Cardiovascular (CV) disease has a significant impact on post-liver transplantation (LT) survival. Finding surrogate markers for occult CV disease would improve CV assessment in the LT evaluation. This study was designed to determine the prevalence of microvascular disease (MVD) and the utility of both microalbuminuria and the homeostatic model for insulin resistance (HOMA-IR) for assessing the presence of MVD in potential LT recipients. In this study, we examined the prevalence of MVD in 72 diabetics and 71 nondiabetics; both groups were matched for age, sex, race, and etiology of cirrhosis while awaiting LT. We prospectively collected data including fasting serum insulin and glucose levels, urine creatinine and microalbumin, and macrovascular and microvascular complications. MVD was present in 58 (40.5{\%}) patients; MVD was more common in diabetics (n = 45, 62.5{\%}) than nondiabetics (n = 13, 18.3{\%}). The presence of diabetes mellitus (DM; P = 0.03), insulin use (P = 0.002), and duration (months) of DM (85.3 ± 96.1 versus 22.1 ± 46.3, P = 0.0001), hypertension (51.3 ± 101.5 versus 22.7 ± 58.2, P = 0.03), and hypertriglyceridemia (7.2 ± 17.4 versus 3.8 ± 18.5, P = 0.04) were associated with MVD. Significant microalbuminuria had a sensitivity of 85{\%}, a specificity of 100{\%}, and a positive predictive value of 100{\%} for the presence of MVD. HOMA-IR also was associated with MVD (P = 0.0001). In conclusion, at our center, 62.5{\%} of DM patients and 18{\%} of non-DM patients awaiting LT have MVD. Patients with DM, significant microalbuminuria, or an elevated HOMA-IR should undergo rigorous CV assessment prior to LT.",
author = "Karen Krok and Farida Milwalla and Anurag Maheshwari and Rebecca Rankin and Thuluvath, {Paul J.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1002/lt.21798",
language = "English (US)",
volume = "15",
pages = "1036--1042",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "9",

}

Insulin resistance and microalbuminuria are associated with microvascular disease in patients with cirrhosis. / Krok, Karen; Milwalla, Farida; Maheshwari, Anurag; Rankin, Rebecca; Thuluvath, Paul J.

In: Liver Transplantation, Vol. 15, No. 9, 01.01.2009, p. 1036-1042.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Insulin resistance and microalbuminuria are associated with microvascular disease in patients with cirrhosis

AU - Krok, Karen

AU - Milwalla, Farida

AU - Maheshwari, Anurag

AU - Rankin, Rebecca

AU - Thuluvath, Paul J.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Cardiovascular (CV) disease has a significant impact on post-liver transplantation (LT) survival. Finding surrogate markers for occult CV disease would improve CV assessment in the LT evaluation. This study was designed to determine the prevalence of microvascular disease (MVD) and the utility of both microalbuminuria and the homeostatic model for insulin resistance (HOMA-IR) for assessing the presence of MVD in potential LT recipients. In this study, we examined the prevalence of MVD in 72 diabetics and 71 nondiabetics; both groups were matched for age, sex, race, and etiology of cirrhosis while awaiting LT. We prospectively collected data including fasting serum insulin and glucose levels, urine creatinine and microalbumin, and macrovascular and microvascular complications. MVD was present in 58 (40.5%) patients; MVD was more common in diabetics (n = 45, 62.5%) than nondiabetics (n = 13, 18.3%). The presence of diabetes mellitus (DM; P = 0.03), insulin use (P = 0.002), and duration (months) of DM (85.3 ± 96.1 versus 22.1 ± 46.3, P = 0.0001), hypertension (51.3 ± 101.5 versus 22.7 ± 58.2, P = 0.03), and hypertriglyceridemia (7.2 ± 17.4 versus 3.8 ± 18.5, P = 0.04) were associated with MVD. Significant microalbuminuria had a sensitivity of 85%, a specificity of 100%, and a positive predictive value of 100% for the presence of MVD. HOMA-IR also was associated with MVD (P = 0.0001). In conclusion, at our center, 62.5% of DM patients and 18% of non-DM patients awaiting LT have MVD. Patients with DM, significant microalbuminuria, or an elevated HOMA-IR should undergo rigorous CV assessment prior to LT.

AB - Cardiovascular (CV) disease has a significant impact on post-liver transplantation (LT) survival. Finding surrogate markers for occult CV disease would improve CV assessment in the LT evaluation. This study was designed to determine the prevalence of microvascular disease (MVD) and the utility of both microalbuminuria and the homeostatic model for insulin resistance (HOMA-IR) for assessing the presence of MVD in potential LT recipients. In this study, we examined the prevalence of MVD in 72 diabetics and 71 nondiabetics; both groups were matched for age, sex, race, and etiology of cirrhosis while awaiting LT. We prospectively collected data including fasting serum insulin and glucose levels, urine creatinine and microalbumin, and macrovascular and microvascular complications. MVD was present in 58 (40.5%) patients; MVD was more common in diabetics (n = 45, 62.5%) than nondiabetics (n = 13, 18.3%). The presence of diabetes mellitus (DM; P = 0.03), insulin use (P = 0.002), and duration (months) of DM (85.3 ± 96.1 versus 22.1 ± 46.3, P = 0.0001), hypertension (51.3 ± 101.5 versus 22.7 ± 58.2, P = 0.03), and hypertriglyceridemia (7.2 ± 17.4 versus 3.8 ± 18.5, P = 0.04) were associated with MVD. Significant microalbuminuria had a sensitivity of 85%, a specificity of 100%, and a positive predictive value of 100% for the presence of MVD. HOMA-IR also was associated with MVD (P = 0.0001). In conclusion, at our center, 62.5% of DM patients and 18% of non-DM patients awaiting LT have MVD. Patients with DM, significant microalbuminuria, or an elevated HOMA-IR should undergo rigorous CV assessment prior to LT.

UR - http://www.scopus.com/inward/record.url?scp=70350532006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350532006&partnerID=8YFLogxK

U2 - 10.1002/lt.21798

DO - 10.1002/lt.21798

M3 - Article

C2 - 19718631

AN - SCOPUS:70350532006

VL - 15

SP - 1036

EP - 1042

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 9

ER -